<DOC>
	<DOCNO>NCT03078959</DOCNO>
	<brief_summary>This observational retrospective study . The primary objective investigate expression potential prognostic role Programmed Death Ligand 1 ( PD-L1 ) tumor sample 350 patient early stage treatment-naive non-small-cell lung cancer ( NSCLC ) . Tissue sample embed tissue microarray . PD-L1 study immunohistochemistry use SP263 antibody . Stained sample evaluate independently two operator . A tumor define positive = &gt; 50 % tumor cell express ligand . The investigator investigate relationship PD-L1 protein expression overall survival clinical characteristic appropriate statistical method .</brief_summary>
	<brief_title>Prognostic Value PD-L1 NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Early stage treatmentnaive NSCLC Received presurgical treatment OS data available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>